Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
The Dawn of a European Health Data Space – Opportunities
Posted on July 9th, 2020 by Mark Siebert in Pharma R&D
At the beginning of 2020, the European Commission introduced a “European strategy for data.” The document proposes to bolster and advance the data economy in Europe with a view towards capturing “the benefits of better use of data, including greater productivity and competitive markets, but also improvements in health and well-being, environment, transparent governance and convenient public services.”
(more…)Readying Your Workforce for Digital Transformation
Posted on June 23rd, 2020 by Paul Dockerty in Pharma R&D
Seeing it as key to innovation and competitive advantage, many businesses in the life sciences are learning to embrace digital transformation these days—in fact, with good reason, most view it as necessary for survival. But whether or not the process of adopting rapidly-evolving digital-age technologies will actually result in business success can really depend on how you do it.
(more…)The FAIR Toolkit Helps Researchers with Data Challenges
Posted on June 16th, 2020 by Ted Slater in Pharma R&D
Since the spread of COVID-19 was first reported, researchers of all types have mobilized to meet the challenges its causative agent, SARS-CoV-2, presents to the world. Data scientists in particular have been quick to apply their expertise to the problems of identifying, tracking and predicting outbreaks; diagnosing COVID-19; identifying infected individuals and detecting non-compliance with virus countermeasures; discovering new therapeutic interventions or repurposing existing ones; and searching for a safe, effective vaccine.
(more…)Infographic: Elsevier’s Professional Services team provides COVID-19 insights
Posted on May 1st, 2020 by Matthew Morton in COVID-19
Check out a special infographic we created to show how Elsevier’s Professional Services team can support your COVID-19 research.
(more…)
